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oriLytHuman cytomegalovirus transient lytic DNA replication relies on the cis-acting element oriLyt, six viral-
encoded core proteins, the proposed DNA replication initiator protein UL84, IE2, IRS1 and the gene products
from the UL112/113 loci. In an effort to elucidate cellular and viral-encoded factors that may play a role in
oriLyt-dependent replication we used DNA-afﬁnity puriﬁcation and mass spectrometry to isolate and identify
several previously unknown cellular and viral factors that interactwithHCMVoriLytDNA. These proteins include
the multifunctional hnRNP-K, BUB3, HMGB1, PTB-1, UL83, UL112/113, and IRS1. Chromatin immunoprecipita-
tion (ChIP) assays conﬁrmed an interaction of several of these factors with oriLyt. Co-immunoprecipitation ex-
periments detected an interaction between UL84 and hnRNP-K in infected and transfected cells. Knockdown
of hnRNP K expression by siRNA inhibited the ampliﬁcation of oriLyt in the transient assay. Together, these
data suggest a possible regulatory role in DNA replication for several previously unidentiﬁed viral and cellular
factors.
© 2011 Elsevier Inc. All rights reserved.Introduction
Human cytomegalovirus (HCMV) DNA replication requires the ac-
tivity of six core proteins, UL54 (polymerase), UL57 (single-stranded
DNA-binding protein), UL102 (helicase), UL105 (primase), UL44
(polymerase-associated factor), and UL70 (primase-associated factor)
(Iskenderian et al., 1996; Pari and Anders, 1993a). In addition to these
core proteins, viral-encoded UL84, IE2 and the cis-acting oriLyt are nec-
essary for efﬁcient lytic DNA replication (Pari et al., 1993). OriLyt is a
3 kb-long DNA element located between ORFs UL57 and UL69 within
the HCMV genome (Zhu et al., 1998). OriLyt is separated into two re-
gions: Essential region I, which contains a bidirectional UL84/IE2-respon-
sive promoter and a oligopyrimidine-rich “Y-block” and Essential region
II, which contains an RNA stem-loop region towhichUL84 binds (Colletti
et al., 2007; Pari, 2008).
Several C/EBPα transcription factor-binding sites are present
within oriLyt and previous studies determined that both UL84 and
C/EBPα interact with these sites (Kagele et al., 2009). Direct interac-
tion between these two proteins was not detected, although binding
to oriLyt in HCMV-infected cells was conﬁrmed by chromatin immu-
noprecipitation assay, suggesting that perhaps UL84 and C/EBPαchool of Medicine, Department
, Cell and Molecular Medicine
ri).
e, Division of Infectious Disease,
, USA.
rights reserved.proteins compete for these binding sites and/or that binding is regu-
lated by viral growth cycle progression or phase of viral infection
(Kagele et al., 2009). Mutations introduced at some of these sites ab-
rogated oriLyt-dependent DNA replication in the transient transfec-
tion assay, demonstrating the importance of these sites and the role
they play in viral genome replication (Kagele et al., 2009). HCMV ori-
Lyt also contains several other transcription factor binding sites, such
as ATF-CREB and SP1, lending the possibility that transcription may
play a role in DNA replication (Anders et al., 1992; Rodems et al.,
1998).
Transcriptional control elements are commonly found in eukary-
otic and viral origins of replication, and may enhance or initiate
DNA replication through transcriptional activation (DePamphilis,
1988). Previous studies have identiﬁed cellular and viral proteins
that bind to the lytic and latent origins in EBV and KSHV. For KSHV
oriLyt, an in vitro approach was taken to elucidate candidate proteins
that may be involved in oriLyt-dependent replication (Wang et al.,
2008). Using this method, PARP-1, APOBEC-3C, DNA-PK, hnRNPs,
and Topoisomerase I and II were found to bind to KSHV oriLyt DNA.
When a similar approach was taken to investigate which proteins
bind to the terminal repeat elements of the KSHV genome, PARP1,
topoisomerase I, and hnRNPs were identiﬁed (Verma et al., 2006).
In another study, TRF 1 and 2, and hnRNPs, were found to bind to
OriP and telomeres of Epstein Barr Virus (Deng et al., 2002). Taken
together, these results suggest a role for cellular factors in replication
of viral DNA in latent and lytic models.
Given the strong association of cellular factors with herpesvirus
lytic origins of replication we investigated if HCMV oriLyt interacts
Table 1
OriLyt binding proteins identiﬁed from a afﬁnity column chromatography.
Protein name Protein score(CI%) Peptide count
UL44 (Pol accessory) 100 22
UL112/113 (pp34) 100 6
UL112(pp84) 100 11
UL112/113 (pp43) 100 11
UL112/113 (pp50) 100 11
UL84 100 8
UL122 (IE2) 100 6
UL57 (ssDNA binding) 100 7
UL83 (pp65) 100 20
UL82 (pp71) 100 22
IRSI 99 6
Microtubule-associated protein, RP/EB family,
member 1 (MAPRE1)
100 9
Uracil DNA glycosylase 100 8
Mitotic checkpoint protein BUB3 100 6
UAP56 100 13
AP endonuclease I 100 13
Heterogeneous nuclear ribonucleoprotein K 100 17
Chaperonin containing TCP1, subunit 3
(gamma)
100 15
TKT protein 100 13
High-mobility group box 1 100 11
Y-box binding protein 100 11
Topoisomerase I & II 100 4 & 7
DNA-PK 100 10
Nucleophosmin 100 5
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and cellular-encoded factors that bind to immobilized oriLyt “bait”
DNA. We followed essentially the same protocol used for identiﬁca-
tion of cellular/viral factors that contribute to KSHV oriLyt and termi-
nal repeat regions (Si et al., 2006; Verma et al., 2006; Wang et al.,
2008). Using this in vitro approach, we were able to conﬁrm the pres-
ence of several viral factors known to interact with oriLyt, as well as
identify both viral and cellular factors previously unknown to bind
to oriLyt DNA. The HCMV replication proteins UL84, UL44, and IE2
were conﬁrmed to bind to oriLyt. In addition, we also identiﬁed inter-
actions between IRS1 and UL112/113 proteins with oriLyt. Some
cellular-encoded proteins, including the mitotic checkpoint protein
BUB3, polypryrimidine tract protein (PTB)-associated splicing factor,
and heterogeneous ribonuclear protein K (hnRNP K) were also
found to bind to immobilized oriLyt DNA, suggesting a possible role
in HCMV DNA replication. Since hnRNP K was shown to have a central
role in other herpesviruses we investigated further the role of this
protein in HCMV lytic DNA replication. We show that hnRNP K inter-
acts with the HCMV UL84 and inhibition of hnRNP K by siRNA knock-
down severely reduces oriLyt ampliﬁcation in the transient
cotransfection replication assay. Together, these results signify a
role for these cellular factors in the regulation of viral DNA replication
and virus growth.
Results
Identiﬁcation of proteins that interact with HCMV oriLyt
To identify proteins that interact with HCMV oriLyt, we used a
DNA-afﬁnity column to capture proteins isolated from HCMV-infected
nuclei. pGEMplasmid containing the oriLyt sequence coupled to a cyan-
ogen bromide-activated sepharose column was incubated with
infected-cell nuclear extract, washed, and bound material eluted with
150 mM, 500 mM, and 1 M NaCl. Bound protein was resolved on an
4–12% polyacrylamide gel and stained with Coomassie Blue (Fig. 1A).
In order to ensure speciﬁc binding to oriLyt sequences and to eliminate
proteins that non-speciﬁcally interact with DNA, we used a column
coupled with pGEM vector DNA. Proteins within nuclear extracts were
bound to each column and subsequently eluted from both columns.
Proteins present in the salt elutions were separated by 2D-gel electro-
phoresis. A paired set of representative 2-D gels is shown (Fig. 1B).
2-D gels were analyzed and protein spots not present in the pGEM con-
trol sample were isolated, digested with trypsin, and the peptides sub-
jected to MS/MS for identiﬁcation. Proteins that were identiﬁed by this
approach are listed in Table 1.
The original transient cotransfection replication assay determined
that eleven viral-encoded loci were required for oriLyt-dependent
DNA replication (Pari and Anders, 1993b). These proteins includedFig. 1. Identiﬁcation of viral and cellular factors that bind to HCMV oriLyt. (A) Increasing salt
Eluates were separated on a 4–12% bis-Tris NuPage gel and stained with Coomassie blue. (B
(left panel) or pGEM (right panel) afﬁnity columns.the splice products of the UL112/113 gene locus, IRS1/TRS1, the
anti-apoptotic proteins UL36-38, along with UL84, IE2, and the
“core” replication proteins common to all herpesviruses (Pari and
Anders, 1993a; Pari et al., 1993). Interestingly, of these proteins
shown to be required for lytic DNA replication in the transient
assay, only UL84, UL44, and IE2 were previously demonstrated to inter-
actwithHCMVoriLyt (Colletti et al., 2007; Kagele et al., 2009). Although
the requirement for IRS1 and UL112/113 proteins was previously
shown by the transient transfection replication assay for oriLyt-
dependent DNA replication, this is the ﬁrst account to show interaction
with oriLyt DNA. Hence, the role of IRS1 and UL112/113 in lytic DNA
replication may involve a mechanism that requires direct or indirect
binding to oriLyt. Other viral proteins not previously implicated in
DNA replication were also identiﬁed such as UL82 and UL83 (Table 1).
RNA-binding proteins such as hnRNP K and PTB also were identiﬁed
as oriLyt binding partners (Table 1), in addition to the DNA damage re-
pair factor HMGB1. Chromosome stability and structure regulatory pro-
teins BUB3 and MAPRE1 also bound to oriLyt DNA under these
conditions, suggesting a previously unknown role of these proteins in
HCMV oriLyt-dependent DNA replication.elutions of afﬁnity-puriﬁed protein bound to oriLyt DNA immobilized on a CNBr column.
) Representative 2-D PAGE gels of eluted protein from 500 mM NaCl elutions for oriLyt
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To conﬁrm the interaction of some of the candidate proteins de-
termined to bind to immobilized oriLyt DNA by MS/MS in the context
of virus-infected cells, chromatin immunoprecipitation assays were
performed. We chose to focus on oriLyt essential region I since this
is where the oriLyt promoter is located since several of the identiﬁed
factors from the proteomic screen are proposed transcription factors.
Also, our goal is to conﬁrm an interaction of identiﬁed proteins with
oriLyt. Speciﬁc antibodies to hnRNP K, UL83, and IRS1 were used to im-
munoprecipitate these proteins and any bound DNA in formaldehyde
cross-linked cells. PCR ampliﬁcation of three regions within oriLyt
was used to detect the interaction of immunoprecipitated proteins
with oriLyt DNA (Fig. 2B). Using this method, we were able to con-
ﬁrm an interaction between hnRNP K and oriLyt. The ChIP assay lo-
calized hnRNP K binding within the oriLyt promoter region, as well
as essential region I (Fig. 2B, lane hnRNP K mab). ChIP assays using
UL83-speciﬁc antibody conﬁrmed an interactionwith UL83 and the ori-
Lyt promoter region (Fig. 2B, lane UL83mab). When IRS1-speciﬁc anti-
body was used to immunoprecipitate protein-DNA complexes, an
interactionwas detected between IRS1 and both the oriLyt promoter re-
gion and essential region I (Fig. 2B, lane IRS1mab). In all regions, both aFig. 2. Veriﬁcation of the association of candidate viral and cellular proteins with HCMV oriL
and speciﬁc antibodies to IRS1, hnRNP K, UL83 were used to immunoprecipitate (A) Schemati
transcription factor binding sites (C/EBPα), RNA/DNA hybrids, oriLyt promoter, essential region
ChIP analysis, designated as “F”, “G”, and “D”. (B) Speciﬁc ampliﬁcation of oriLyt DNA immunopr
protein was used as a negative control. Also shown is the result from the use of primers to an
assay. Input samples were 1.8% of total lysate. 16% of lysate was used for immunoprecipita
input. Forty percent of the PCR product was loaded on the agarose gel.water control and an antibody of the same isotype were unable to pro-
duce an ampliﬁcation product. Additionally, a control ChIP PCR ampliﬁ-
cation using primers to a region of the HCMV genome unrelated to
oriLyt did not produce a PCR product (Fig. 2B, panel UL114 locus).
ChIP analysis was not performed for proteins UL84, UL44, and IE2, as
we have characterized their binding across oriLyt in previous studies
(Colletti et al., 2007; Kagele et al., 2009). Together, these results conﬁrm
the presence of an interaction between these candidate proteins identi-
ﬁed by DNA afﬁnity puriﬁcation and strongly suggest that the cellular
protein hnRNP K and the viral proteins IRS1 and UL83 interact with ori-
Lyt DNA.
UL84 interacts with hnRNP K
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a cellular
protein that has a diverse set of functions. In addition to RNA processing
and transport, hnRNP K also has roles in transcription regulation and
signal transduction (Mikula et al., 2006), shuttles between the nucleus
and cytoplasm, and facilitates the interaction between regulatory pro-
teins and kinases (Bomsztyk et al., 2004). KSHV ORF57 and HSV-1
ICP27, both of which have been shown to interact with hnRNP K,
share many similar functions with HCMV UL84. We thus performedyt by ChIP assay. AD169-infected HFF cells were formaldehyde cross-linked, sonicated,
c representation of HCMV Orilyt. Shown are the relative locations of previously identiﬁed
s I and II and the stem-loop structures within oriLyt. Also shown are regions ampliﬁed for
ecipitated by speciﬁc antibodies to candidate genes. The antibody speciﬁc for KSHVK-bZIP
HCMV genomic unrelated locus (UL114) using immunoprecipitated DNA from each ChIP
tion experiments. Two percent of the sample was used for PCR ampliﬁcation including
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UL84 and hnRNP K. AD169-infectedHFF cell protein extractswere incu-
batedwith an hnRNP K-speciﬁc antibody and immunoprecipitated pro-
tein complexeswere subjected towestern blot analysis using anti-UL84
speciﬁc antibody. Under these conditions UL84 was co-
immunoprecipitated with hnRNP K (Fig. 3, panel A, top panel lane 2).
We also performed the reverse co-immunoprecipitation where we
used a UL84 speciﬁc antibody to immunoprecipitate hnRNP K from
infected cell protein lysates (Fig. 3, Panel A, bottom panel, lane 2).
Since UL84 and hnRNP K are known to interact directly with DNA
and/or RNA, samples were treated with RNase and DNase, and an inter-
action between the two proteins was still detected (Fig. 3, Panel A lane
DNase/RNase treatment). As a control for DNase treatment, protein ly-
sates were evaluated for the presence of DNA after DNase treatment.
DNA cleavage was observed in both lysates that were DNase-treated
(Fig. 3, Panel B). A control immunoprecipitation was also performed
using an antibody of the same isotype (anti-K-bZIP), no immunopreci-
pitated product was observed (Fig. 3A, lane 5).
Our next stepwas to determine the interaction domains for hnRNPK
and UL84 proteins. We generated several plasmids that expressed dif-
ferent regions of the UL84 protein (Fig. 3C). Plasmids expressing
hnRNP K and the various fragments of UL84 were co-transfected into
HEK293FT cells and co-immunoprecipitation experiments were per-
formed. The UL84 plasmid clone that expressed amino acids 344–586
was capable of interacting with hnRNP-K (Fig. 3D, lane Δ1−343
+hnRNPK, IP:hnRNP K). However, a plasmid that expressed amino
acids 400–586 of the UL84 protein failed to interact with hnRNP K
(Fig. 3D, lane Δ1−399+hnRNP K, IP: hnRNP K). Hence, the region of
interaction of UL84 with hnRNP K lies between amino acids 343–400.
These results show that hnRNP K interacts with the HCMV replication
protein UL84 and suggests a wider role for the protein in lytic DNA rep-
lication. Control immunoprecipitations, using the same isotype but
unrelated antibody, showed no speciﬁc interaction (Fig. 3E).Fig. 3. UL84 interacts with hnRNP K in infected and transfected cells. HFF cells were infected
monoclonal antibody speciﬁc to UL84. Transfected cell immunoprecipitations were perform
immunoprecipitated with rabbit polyclonal antibody against hnRNP K. Forty percent of the
UL84 and hnRNP K immunoprecipitation in infected cells. (B) Ethidium bromide staining of
of UL84 interaction domains and plasmids expressing fragments of UL84. (D) Western blot a
hnRNP K in transfected cells. Arrowheads indicate the fragment of interest in each lane. (E) CoBoth UL84 with hnRNP K are dispersed throughout the nucleus in
HCMV-infected cells
Because immunoprecipitation experiments in both infected and
transfected cells detected an interaction between UL84 with hnRNP
K we next decided to perform immunoﬂuorescence assays to investi-
gate the localization of UL84 and hnRNP K in an infected cell environ-
ment. Quantitative PCR and western blot analyses of hnRNP K gene
expression over the time course of infection failed to demonstrate
any difference in gene expression (data not shown), so we also
wanted to determine if the subcellular localization of hnRNP K was af-
fected by HCMV infection.
hnRNP K localizes primarily to the nucleus though slight cytoplas-
mic distribution is observed in uninfected cells (Schmidt et al., 2010).
Cells infected with AD169 were reacted with antibodies to UL84 and
hnRNP K 1 dpi and 5 dpi. FITC-conjugated secondary antibody was
used to visualize UL84 and Alexa555-conjugated secondary antibody
to visualize hnRNP K. UL84 and hnRNP K were both dispersed
throughout the nucleus in infected cells as early as 1 dpi (Fig. 4). Incu-
bation with anti-hnRNP K antibody showed small, punctate struc-
tures as opposed to the smooth and diffuse staining of UL84. 5 days
post-infection some apparent co-localization of UL84 and hnRNP K
was observed, suggesting that an interaction persists during early
and late infection, however no speciﬁc staining pattern was observed.
This suggests UL84 and hnRNP K interact but do not form any speciﬁc
localized structures within the nucleus of infected cells. No staining
was observed for UL84 in mock-infected cells (Fig. 4). For hnRNP K,
mock infection showed a similar pattern to that observed in infected
cells, suggesting that the presence of virus does not redistribute the
protein. This is also consistent with the fact that HCMV infection has
no effect on the level of hnRNP K protein expression (not shown). To-
gether, these data suggests that theHCMVUL84 andhnRNPK is localized
in the nucleus of infected cells.with AD169, harvested 3 dpi, and protein complexes immunoprecipitated with mouse
ed using HEK 293FT cells transfected with the respective plasmids, harvested 2 dpi, and
lysate was used for IP, 1% was used for gel electrophoresis. (A) Western blot analysis of
DNAsed- and RNased- crude lysates run on an 0.8% agarose gel. (C) Schematic diagram
nalysis of expression plasmids containing fragments of UL84 interacting with full-length
ntrol immunoprecipitations using isotype speciﬁc unrelated antibody.
Fig. 4. HCMV UL84 hnRNP K are both localized to the nucleus in infected cells. HFF cells were infected with AD169 virus and cells were visualized for the presence of UL84 and
hnRNP K by immunoﬂuorescence using speciﬁc antibodies at 1 and 5 dpi. Images were photographed at a magniﬁcation of 100× using FITC- or Alexa-555 secondary antibodies.
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ChIP analysis showed hnRNP K interacted with oriLyt DNA within
the same regions as UL84, IE2, and UL44 (as shown in previous stud-
ies from our laboratory). For this reason, and because UL84, UL44 and
IE2 apparently form a complex in infected cells, we hypothesized that
these replication proteins may interact with hnRNP K collectively or
may affect the interaction between UL84 and hnRNP K. To investigate
this hypothesis, co-immunoprecipitation experiments wereFig. 5. UL44 and IE2 enhance the interaction of UL84 with hnRNP K. (A) HEK 283FT cells were
the addition of UL44 (1 μg) and IE2 (1 μg). Immunoprecipitations were performed using rabb
antibodies for UL84, UL44, and hnRNP K. Graph showing the increase in association of hnRNP
cotransfected with plasmids expressing UL84, IE2 and hnRNP K. (B) Control immunoprecipitat
precipitations were performed using anti-K-bZIP antibody.performed in HEK 293FT cells co-transfected with plasmids expres-
sing UL84 and hnRNP K, with the addition of UL44 and IE2 expression
plasmids. Empty pGEM plasmid was also used to keep the amount of
DNA transfected constant between samples. Upon the addition of a
UL44 expression plasmid along with hnRNP K and UL84 expression
plasmids, immunoprecipitations using hnRNP K speciﬁc antibody
was able to immunoprecipitate more UL84, suggesting an increase
in the stability of the interaction between the two proteins (Fig. 5,
panels A and B). When both UL44 and IE2 expression plasmids weretransfected with plasmids expressing full-length UL84 (2 μg) and hnRNP K (1 μg), with
it polyclonal anti-hnRNP K antibody. Western blot analysis was performed using speciﬁc
K with UL84 in the presence of IE2 and UL44. Also shown is a western blot for samples
ions using an isotype speciﬁc antibody. Cell were cotransfected as described and immuno-
Fig. 6. hnRNP K expression is essential for oriLyt-dependent lytic DNA replication. (A,
left panel) siRNA knockdown of hnRNP K expression. Western blot of protein extracts
from HF cells transfected with siRNA or scramble oligonucleotides 24 h prior to
cotransfection of plasmids required for transient complementation of oriLyt ampliﬁcation.
Western blot was reacted with an antibody speciﬁc for hnRNP K. (Right panel) MTT assay
for cells transfected with hnRNP K siRNA, scramble siRNA or untransfected. Cells were
transfected and evaluated 5 days post treatment. (B) Southern blot of total cellular DNA
cleaved with EcoRI/DpnI and hybridized with pGEM plasmid from transient cotransfection
replication assay from HF cells treated with siRNA speciﬁc for hnRNP K mRNA or scramble
oligonucleotides. Lanes: 1, DNA from cell cotransfected with all the required plasmids
expressing replication proteins plus oriLyt; 2, DNA from cell cotransfected with all the re-
quired plasmids expressing replication proteins, oriLyt plus siRNA speciﬁc for hnRNP K
mRNA; 3, DNA from cell cotransfectedwith all the required plasmids expressing replication
proteins, oriLyt plus scramble siRNA oligonucleotide; 4, DNA from cell cotransfectedwith all
the required plasmids expressing replication proteins minus the UL84 encoding plasmid
plus oriLyt. Arrow indicates DpnI-resistant replicated oriLyt plasmid.
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hnRNP K was enhanced as compared to UL84 and hnRNP K by them-
selves or with the addition of the UL44 expression plasmid alone
(Fig. 5, panels A and bar graph below). Control immunoprecipitations
using an isotype speciﬁc antibody (anti-K-bZIP) failed to show immu-
noprecipitated products (Fig. 5B). The addition of an IE2 expression
plasmid with hnRNP K and UL84 expression plasmids failed to in-
crease the interaction between hnRNP K with UL84 (Fig. 5A, lane,
hnRNP K+UL84+IE2). These results, coupled with the data from
our ChIP experiments, suggest that hnRNP K interacts with UL44,
IE2 and UL84 in a cooperative manner.
hnRNP K expression is required for oriLyt-dependent DNA replication
Since we show that hnRNP K interacted with oriLyt and is a bind-
ing partner for UL84, we wanted to examine if hnRNP K expression
was required for efﬁcient lytic DNA replication. Using the transient
cotransfection replication assay, where ampliﬁcation of HCMV oriLyt
is used as a reporter for lytic DNA synthesis, we can observe the effects
of silencing the expression of hnRNP K directly on DNA replication. We
transfected siRNA oligonucleotides speciﬁcally designed to knock down
hnRNP K mRNA in cells that were subsequently cotransfected with the
required HCMV replication protein expression plasmids plus a plasmid
containing oriLyt. Hence, if hnRNP K expression was required for oriLyt
ampliﬁcation then wewould observe a decrease in ampliﬁcation of ori-
Lyt under conditions where hnRNP K is expression is silenced. Cells
treated with siRNA speciﬁc for hnRNP K mRNA resulted in a signiﬁcant
suppression of hnRNP K protein expression (Fig. 6A, left panel). No ap-
parent cellular toxicity was observed based on the results of an MTT
assay performed on cells treated with scramble or hnRNP K siRNA
(Fig. 6A, right panel). Cells treated with siRNA directed against hnRNP
K mRNA were subsequently used in the cotransfection replication
assay. Cells treatedwith hnRNPK siRNA showed an almost complete in-
hibition of ampliﬁcation of the oriLyt plasmid compared to untreated
cells (Fig. 6B, lane 1 and 2, respectively). The siRNA scramble sequence
had no effect on ampliﬁcation of oriLyt (Fig. 6B lane 3). This experiment
strongly suggests that expression of hnRNP K signiﬁcantly contributes
to HCMV DNA replication.
Discussion
Due to the limited size of viral genomes, viruses are unable to en-
code all protein necessary to complete its life cycle, and therefore rely
on a variety of cellular factors to accomplish this task. In the present
study, we used immobilized “bait” HCMV oriLyt DNA coupled with
MALDI-TOF/TOF analysis to identify candidate proteins that may in-
teract with oriLyt. A growing interest in cellular factors that interact
with herpesvirus DNA elements has recently evolved as well as the
interplay of viral and cellular proteins and these effects on viral
DNA replication, however a proteomics-based approach for HCMV
oriLyt has not previously been performed. Here we have successfully
conﬁrmed the interaction of several known replication proteins with
oriLyt, in addition to identifying several cellular factors previously
unidentiﬁed. We controlled for non-speciﬁc binding in our afﬁnity
column using plasmid DNA. This approach should discriminate be-
tween proteins that interact with DNA at different afﬁnities based
on salt stringency. Hence, each set of salt concentration elutions were
matched in subsequent 2D gel analysis. Identiﬁed protein interactions
were then of course veriﬁed using ChIP assays. Additionally, we used
methods previously employed in other herpesvirus systems to eluci-
date factors that interact with cis acting elements. Hence, we have
high conﬁdence that the method used here yielded accurate results.
Two regions of oriLyt were ampliﬁed for these assays: the oriLyt
promoter region and essential region I. IRS1, hnRNP K, and UL83 pro-
teins were shown to interact with these regions within oriLyt. IRS1
was determined to bind to oriLyt DNA at the oriLyt promoter region,a novel function for this replication protein. IRS1, which has been well
characterized, has recently been shown to interact with UL44 as a
part of a larger replication protein complex (Strang et al., 2010).
The gene product of either IRS1 or TRS1 is required for efﬁcient
oriLyt-dependent DNA replication, and deletion of both abrogates
lytic DNA replication in the context of the virus genome indicating
that the gene product of either IRS1 or TRS1 is required for virus
growth (Marshall et al., 2009; Pari et al., 1993). Recent studies from
our laboratory have also demonstrated an interaction between UL84
and IRS1 mRNA (Gao et al., 2010). IRS1 acts as a transactivator at
the UL44 locus along with IE2, and is required for oriLyt-dependent
DNA replication in the transient transfection replication assay using
native promoters (Pari et al., 1993). MS/MS analysis identiﬁed IRS1
to bind to oriLyt DNA in the current study in the oriLyt promoter re-
gion and essential region 1. UL44 also interacts with these regions,
and though IRS1 is required for lytic DNA replication, its function
112 D. Kagele et al. / Virology 424 (2012) 106–114has been poorly understood. Here we provide evidence that IRS1
binds to oriLyt DNA, and may be part of a complex with UL44, IE2
and UL84 to initiate DNA replication.
We also demonstrate in the present study that the viral initiator
protein UL84 interacts with the cellular factor hnRNP K, and this in-
teraction is enhanced with the addition of UL44 and IE2. Our original
proteomics assay failed to identify hnRNP K as a binding partner for
UL84 (Gao et al., 2008). Although this early study identiﬁed many
binding partners for UL84 we could not exclude the possibility that
other proteins interact with UL84 in infected cells. The UL84 ORF re-
gion between aa 350 and 400 is implicated in this interaction. Our at-
tempts to overexpress the aa 350–400 peptide were not successful. A
UL84 ORF with a deletion in this region failed to interact with hnRNP
K that strongly suggests this region of the protein is the interaction
domain, however improper folding of UL84 may be the reason for a
non-interaction. These results suggest these proteins form a complex
within infected cells. It is known that UL84, UL44, and IE2 form a rep-
lication complex early in infection, and it is possible that hnRNP K
may also be a member of this complex to regulate DNA replication
and/or transactivation. Further experiments must be performed to
explore this possibility.
hnRNP K and UL84 share many similar functions, including bidi-
rectional nucleocytoplasmic shuttling (Gao et al., 2010; Lischka et
al., 2006), ability to interact with and translocate RNA, and regulate
gene expression through transcriptional activation. A similar interac-
tion has been observed in other herpesviruses between a viral repli-
cation protein and hnRNP K: Herpes simplex virus 1 ICP27 and
KSHV ORF57 have been shown to interact with hnRNP K in previous
studies, and both proteins also have similar functions to UL84. One
possible explanation for the interaction between hnRNP K and UL84
is that hnRNP K loans its functionality to UL84, thereby allowing
UL84 to perform these functions and interact with speciﬁc virus-
encoded proteins and RNAs. Another possible explanation for the in-
teraction is that UL84, UL44, IE2, and hnRNP K form a pre-replication
complex, where hnRNP K acts as a docking point for replication pro-
teins to gather and assemble replication complexes to initiate DNA
replication. Our data suggests that the activity of hnRNP K is essential
in the context of lytic DNA replication.
The tegument protein pp65 is the viral gene product of UL83 and
is abundantly synthesized during lytic infection. After adsorption of
the virus, pp65, via distinct nuclear localization signals, localizes to
the nucleus, where its function is not known (Schmolke et al.,
1995). In our study, we show for the ﬁrst time that pp65 binds to
the oriLyt promoter in infected cells, demonstrating a new function
for the phosphoprotein. Recent data provides evidence of pp65 acting
as a transactivator at the major immediate early promoter, which
controls the transcription of IE2 (Cristea et al., 2010). UL83 also
binds to UL84 (Gao et al., 2008), and because UL84 is both a compo-
nent of the virion and binds directly to oriLyt DNA, it is possible
that UL83 may tether UL84 to the matrix of the virion, thereby play-
ing a structural role in its association to oriLyt. Another possibility is
that UL83, through its UL84 binding, interacts indirectly with oriLyt
to regulate its function in some other manner.
A similar approach using biotinylated fragments of KSHV oriLyt
was employed to explore the possible regulation of lytic DNA replica-
tion via cellular factors (Wang et al., 2008). Cellular proteins involved
in DNA replication and repair such as RecQL, PARP-1, and Topo I and II
were found to bind to KSHV oriLyt. TPA-induced BCBL-1 cells were
used to conﬁrm the interaction of these proteins with oriLyt-L in a
lytic-reactivated platform. hnRNP K was shown to bind to KSHV ori-
Lyt, and was also found in our experiments to bind to HCMV oriLyt,
however, no other proteins identiﬁed in this investigation matched
proteins identiﬁed in the KSHV oriLyt proteomics study. One possible
explanation for this occurrence is that BCBL-1 cells harbor primarily
latent genomes and induction is required to generate lytic replication,
whereas HFF cells infected with AD169 are only able to produce alytic infection. An altered cellular environment, or perhaps a different
virus phenotype due to the inability of AD169 to establish a latent in-
fection could possibly explain why no other cellular factor binding
were shared between the two origins of lytic replication.
The results of this study suggest new roles for proteins not previously
implicated in viral DNA replication, both of viral and cellular origin.
hnRNP K and HMGB1 were found to bind to oriLyt DNA, as well as
IRS1, IE2, UL44, pp65, among others. One set of viral proteins previously
not shown to interact with oriLyt, but are required for lytic DNA replica-
tion in the transient transfection assay using native promoters is the
product of the gene locus UL112/113. Recent studies have shown p84,
a splice product of UL112/113, to interact directly with the polymerase
processivity factor UL44 (Kim and Ahn, 2010). This interaction inﬂu-
ences oriLyt-dependent lytic DNA replication, and now results from
MS/MS analysis identiﬁed UL112/113 gene products to interact with ori-
Lyt DNA. Further experiments are currently being performed to deter-
mine if this interaction is direct or indirect, and if it occurs in an
infected cell environment. All of these data taken together suggest a
novel mechanism in which the virus interacts with and utilizes host fac-
tors to achieve genome replication.
Materials and methods
Cells and virus
Human foreskin ﬁbroblasts were propagated in Dulbecco's modi-
ﬁed Eagle medium (DMEM) supplemented with 10% (vol/vol) fetal
bovine growth serum (HyClone). HCMV strain AD169 (ATCC VR-
538) was maintained as frozen stocks and propagated as described
previously (Smith and Pari, 1995). HEK293FT cells were maintained
with Dulbecco's modiﬁed Eagle medium (DMEM) supplemented
with 10% (vol/vol) bovine growth serum (Atlanta Biologicals).
Plasmids
pTarget UL84-HA, pTarget UL84 aa1-355-HA, pTarget UL84 aa
344-586-HA, and pTarget UL84 400-586-HA were made by PCR ampli-
ﬁcation of AD169 DNA and ligated into pTarget. Nucleotide coordinates
for full-length UL84-HA were nt 3536 for forward and nt 5293 for re-
verse primer. Nucleotide 3536 for forward and nt 4600 for reverse
primer was used to amplify amino acids 1–355 of UL84. Nucleotide
4565 for forward and nt 5293 for the reverse primer was used to gener-
ate the UL84 aa 344–586 fragment. Nucleotide 4733 for forward primer
and nucleotide 5293 for the reverse primer was used to create the UL84
aa400-586 fragment. PCR products were generatedwith hemagglutinin
(HA) tag fused at the 3′ end of the UL84 ORF. hnRNP K expression plas-
mid was a kind gift from Dr. Matthias Hentze (Humboldt University of
Berlin). The IE2-FLAG plasmid was constructed as described previously
(Xu et al., 2004). pTarget UL44-HA was made by cloning amino acids
1–433 of ORF UL44 of the HCMV genome into the pTarget vector (Pro-
mega) along with an in-frame hemagglutinin (HA) tag on the
C-terminus of ORF UL44.
Nuclear extract preparation
Nuclear extracts were prepared from HF cells infected with AD169
using Sigma NXTRACT CelLytic NuCLEAR extraction kit according to
the manufacturer's protocol. Brieﬂy, 3×106 HF cells were infected at
MOI=10 and 5 days post infection were washed with PBS twice
and scraped from the ﬂask in PBS. Cells were centrifuged at 450 ×g
for 5 min, the supernatant removed, and resuspended in hypotonic
lysis buffer plus protease inhibitors and 0.1 M DTT. The suspension
was incubated at room temperature for 15 min, centrifuged at
450 ×g for 5 min, and the supernatant removed. Hypotonic lysis buffer
with protease inhibitors and DTT was added, and the cells were
dounce-homogenized (type B pestle) with seven strokes on ice.
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centrifuge for 10 min at 4 °C and the cytoplasmic fraction (supernatant)
was transferred to a new tube. The pelletwas resuspended in extraction
buffer, homogenized with 10 strokes, and gently shaken for 30 min at
4 °C. Extracted nuclei were collected by centrifugation for 10 min at
13,000 rpm, and the supernatant (containing nuclear protein) was
snap frozen and stored at−80 °C.
Column preparation and nuclear extract binding
OriLyt plasmid, which contained the 3Kb HCMV fragment from nts
89797 to 94860 was cleaved with KpnI and HindIII to release the ori-
Lyt region. The oriLyt fragment was puriﬁed by gel electrophoresis
where the band was extracted using Qiagen gel extraction kit. As a
control, pGEM7zf(−) was cleaved with EcoRI. OriLyt DNA was incu-
bated with CNBr-activated Sepharose (GE Healthcare, Milwaukee,
WI) according to the manufacturer's protocol. The unbound reactors
were inactivated, and the Sepharose was extensively washed with
binding buffer and packed into an Econocolumn (Bio-Rad Laboratories,
Inc., Hercules, CA). Nonspeciﬁc DNA binding was absorbed with 125 μg
of poly(dI-dC) (GE Healthcare, Milwaukee, WI).
The nuclear extracts were diluted 1:4 with buffer A (10 mM
HEPES, 10 mM KCl, 1.5 mM MgCl2, 5 mM dithiothreitol [DTT]) plus
mammalian protease inhibitor cocktail (Calbiochem) and loaded to
the Sepharose column or the control column. The elutant that passed
through the Sepharose fraction was stored as the unbound fraction.
After the column was washed with buffer A, the bound proteins
were eluted with the same buffer containing sequentially increasing
concentrations (150, 500, and 1000 mM) of NaCl. Eluted proteins
were denatured by boiling in sample buffer and then separated on a
4–12% bis-Tris NuPage gel (Invitrogen) and visualized by Coomassie
blue staining. Proteins separated by 2D gel electrophoresis were iden-
tiﬁed by mass spectrometry.
2-D gel electrophoresis, imaging and comparison of protein spots, protein
digestion and MS
All 2-D gel electrophoresis and protein identiﬁcation were carried
out as previously described where we used protein Ion score of at
least 99 as a cut off (Gao, Colletti, and Pari, 2008).
Antibodies
The UL84-speciﬁc monoclonal antibodyMAb84 has been previously
described (Colletti et al., 2004). The IE1/2-speciﬁc antibody was pur-
chased from Millipore (catalog number MAB810). Anti-HCMV UL44
mouse monoclonal antibody was a generous gift from William Britt
(University of Alabama School of Medicine). hnRNP K-speciﬁc antibody
was purchased from Cell Signal (catalog number 4675S). The
UL83-speciﬁc antibody was purchased from Virusys (catalog number
CA003-100). The anti-HCMV IRS1monoclonal antibodywas kindly pro-
vided by T. Shenk (PrincetonUniversity). HMGB1-speciﬁc antibodywas
purchased fromCell Signal (catalog number 3935S). BUB3-speciﬁc anti-
body was purchased from Santa Cruz Biotechnology (catalog number
sc-28257).
Chromatin immunoprecipitation (ChIP)
1×107 HF cells were infected with AD169 at MOI=10 for 3 days.
Samples were ﬁxed for 10 min with 1% formaldehyde, washed twice
with 1× PBS, and lysed for 15 min in lysis buffer (50 mM Tris–HCl,
150 mM NaCl, 1% Triton X-100, 0.1% Tween 20, 1 mM EDTA). Samples
were sonicated, diluted sixfold with ChIP buffer (12.5 mM Tris, pH 8,
200 mM NaCl, 1% Triton X-100) and precleared with mouse immuno-
globulin G-AC (Santa Cruz Biotechnology) at 4 °C for 30 min. For each
immunoprecipitation, 10 μL of each antibody was incubated with thelysate at 4 °C overnight. No-antibody and antibody isotype control
immunoprecipitations were also performed. Protein G-Plus-agarose
beads (Santa Cruz Biotechnology) were blocked with 10 μg of sheared
salmon sperm DNA and bovine serum albumin at 4 °C overnight and
then washed with ChIP buffer. The blocked and washed protein
G-Plus beads were incubated with the lysate at 4 °C for 1 h. The
beads were washed once with low-salt buffer (0.1% SDS, 0.1% Triton
X-100, 2 mM EDTA, 20 mM Tris, pH 8, 150 mM NaCl), once with
high-salt buffer (0.1% SDS, 0.1% Triton X-100, 2 mM EDTA, 20 mM
Tris, pH 8, 500 mM NaCl), once with LiCl buffer (0.25 M LiCl, 1%
NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris pH 8), and twice
with Tris-EDTA (TE). Beads were resuspended in TE, incubated with
RNase A at 37 °C for 30 min, and then incubated with proteinase K
and 10% SDS at 37 °C for 4 h, followed by incubation at 65 °C overnight.
For input control samples, NaCl was added to the sonicated lysate to a
ﬁnal concentration of 0.3 M and incubated at 65 °C overnight. After
the antibody, no-antibody, and isotype control immunoprecipitated
samples were ﬁltered through a 0.45-μm ﬁlter to remove the agarose
beads, they were extracted with phenol-chloroform and ethanol pre-
cipitated. DNA was then used as a template for PCR with primers that
spanned the oriLyt region, or, in the case of a control sample, PCR
primers from the HCMV UL114 locus were used. Primer sequences GR
(5′-gtcgtgtatacataacggtgcccggtgt-3′) and GF (5′-gttggtcacgtgaccatcagcg-
caggaa-3′) to amplify oriLyt region between nucleotides 91319–91660
of the HCMV genome; FR (5′-agcgaggcccgtagaaccgcccaaga-3′) and FF
(5′-ttagggttccaccgtcctcggtgtacg-3′) for the oriLyt region betweennucleo-
tides 91600–91958; and D1R (5′-ttctaacgaaacgttctacgaaaacgg-3′) and
D1F (5′-acgcggattatgggatggtgactcgagt-3′) to detect oriLyt between nu-
cleotides 92418–92642.
Co-immunoprecipitation assay
For transfected cell assays, HEK 293FT cells were plated to 60 to
70% conﬂuency in 100-mm dishes. Cells were transfected with 10 μg
of the appropriate plasmids by using TransIT LT reagent (Mirus) per
manufacturer's recommendations. 48 h posttransfection cells were
washed twice with PBS (pH 7.4) and lysed using 1 ml of lysis buffer
(50 mM Tris–HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 0.5% NP-40,
0.2 mM EDTA, 10 μl of protease inhibitor cocktail/mL lysate) and ro-
tating for 30 min at room temperature. Cells were scraped from the
plate and sonicated for 90 s with 10-second pulses. Cellular debris
was removed by centrifugation at 1500 ×g for 5 min and lysates
were incubated with the appropriate monoclonal antibody for 1 h at
4 °C. 50 μl of protein G plus agarose beads was added and the lysates
were incubated at 4 °C overnight. The complexes were washed with
ice-cold PBS (pH 7.4) three times. The protein complexes were re-
moved from the beads by the addition of 2× Laemmli sample buffer
(Bio-Rad) containing 2-mercaptoethanol and then heated to 95 °C
for 5 min. Samples were separated by SDS-PAGE and analyzed by
Western blot. For infected cell immunoprecipitations, HFF cells were
plated to 60–70% conﬂuency and the next day infected with AD169
at an MOI of 5. 3 days post infection, expressed protein was harvested
as described above. For DNase-treated samples, 2 μL of Turbo DNase
(Ambion, catalog number AM2238) was added to each sample,
which were incubated at 37 °C for 15 min. RNase-treated samples
were incubated with RNase A (US Biologicals) for 15 min at room
temperature.
Immunoﬂuorescence assay
HFF cells plated onto coverslips were infected with AD169 virus at
anMOI of 5. 1 dpi and 5 dpi cells were ﬁxed with 4% paraformaldehyde
in PBS for 10 min and washed three times in PBS. Cells were permeabi-
lized in 0.2% Triton in PBS for 20 min, washed in PBS three times and
blocked with 0.2% ﬁsh skin gelatin in PBS for 20 min at room tempera-
ture, and incubated for 1 h with primary antibody in 0.2% ﬁsh skin
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times, and FITC- or AlexaFluor555-conjugated secondary antibody at a
dilution of 1:250 in 0.2% ﬁsh skin gelatin in PBS was incubated with
the cells for 1 h. Cells were rinsed with PBS three times, incubated
with DAPI stain in PBS for 5 min, rinsed again twice, and mounted
using ProLong Gold Anti-fade reagent (Invitrogen). Cells were visual-
ized using a Zeiss AIX0 confocal microscope.
Transient cotransfection replication assay
Cell were treated as previously described (Pari and Anders, 1993a).
For siRNA experiment, cells were transfected with siRNA (see below)
for two consecutive days and 24 h later cells were again transfected
with plasmids required for the cotransfection replication assay.
hnRNPk knockdown using siRNA
hnRNPK was selectively targeted for reduced protein expression
using siRNA speciﬁc to hnRNPK. 50 nM of Silencer Select siRNA (Ap-
plied Biosystems, hnRNPK siRNA ID: s6737) either speciﬁc for hnRNPK
mRNA or scramble control siRNA was introduced into 2×105 cells
using siPort NeoFX transfection agent (Applied Biosystems) according
to manufacturer's instructions.
MTT cell viability assay
5×104 cells were transfected with 50 nM of either siRNA speciﬁc
to hnRNPK or scramble control using siPort NeoFX and plated in trip-
licate into a 96-well plate, the ﬁnal culture volume was 100 μL. Cells
were transfected a second time 24 h later and 120 h post transfection
cell viability was evaluated using CellTiter 96 (Promega) usingmanufac-
turer's instructions. Absorbance was read at 570 nm using a Molecular
Devices 96-well plate reader with SoftMax Pro software.
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